Dr. Agarwal’s Health Care Limited has confirmed the successful completion of all regulatory requirements regarding the dematerialization and rematerialization of its securities for the quarter ended March 31, 2026. The company’s Registrar and Share Transfer Agent, KFin Technologies Limited, has verified that all necessary data has been formally furnished to the relevant depositories. This ensures transparency and compliance in the handling of shareholder security records for the final quarter of the fiscal year.
Quarterly Compliance Update
Dr. Agarwal’s Health Care Limited has officially communicated the completion of its mandatory security documentation procedures for the quarter concluding on March 31, 2026. Through its designated Registrar and Share Transfer Agent, KFin Technologies Limited, the company has ensured that all records pertaining to the dematerialization and rematerialization of shares have been processed and accurately reported.
Verification of Shareholder Records
The confirmation covers the entirety of the fourth quarter (Jan-Mar 2026), affirming that all relevant data regarding changes in share status has been transmitted to both the National Securities Depository Limited (NSDL) and the Central Depository Services (India) Limited (CDSL). This periodic verification process is a standard operational procedure aimed at maintaining the integrity of the company’s shareholding records and facilitating smooth electronic trading for investors.
Source: BSE
